4581 — Taisho Pharmaceutical Holdings Co Balance Sheet
0.000.00%
Last trade - 00:00
- ¥702bn
- ¥461bn
- ¥301bn
- 71
- 35
- 96
- 81
2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 358,467 | 237,903 | 254,195 | 272,268 | 256,166 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 71,132 | 65,014 | 51,176 | 53,265 | 51,925 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 469,781 | 355,623 | 357,731 | 378,864 | 375,880 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 91,283 | 112,648 | 113,194 | 119,291 | 141,170 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 821,782 | 864,974 | 876,923 | 888,159 | 941,490 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 58,453 | 66,456 | 57,666 | 62,277 | 73,778 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 108,810 | 154,826 | 147,417 | 140,008 | 154,923 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 712,972 | 710,148 | 729,506 | 748,151 | 786,567 |
Total Liabilities & Shareholders' Equity | 821,782 | 864,974 | 876,923 | 888,159 | 941,490 |
Total Common Shares Outstanding |